http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011269-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6493e6955f028f92bf9df7dc31b866bd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
filingDate 2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e720ddf67c5f1cc44e3372b3f134d9
publicationDate 2003-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03011269-A1
titleOfInvention Agent for treating the symptoms of dementia disorders containing an additional local anesthetic agent
abstract The invention relates to an agent used for producing a medicament for treating dementia disorders, in which a treatment of this illness that is more effective than classical therapy is achieved by an active ingredient combination consisting of a substance, which increases the dopamine concentration in the synaptic gap of the nerve cells of the brain, with a local anesthetic agent of the anilide group.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2213285-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2213285-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8519006-B2
priorityDate 2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5942241-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6133299-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5064858-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5891885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0032232-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127920744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128885255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127977224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31101

Total number of triples: 53.